Nephron Dialysis Center, Ltd. is a medicare approved dialysis facility center in Chicago, Illinois and it has 16 dialysis stations. It is located in Cook county at 5140 N. California Ave., Chicago, IL, 60625. You can reach out to the office of Nephron Dialysis Center, Ltd. at (773) 293-2100. This dialysis clinic is run as an independent entity, i.e. it is not owned by any chain organization. Nephron Dialysis Center, Ltd. has the following ownership type - Profit. It was first certified by medicare in June, 2000. The medicare id for this facility is 142600 and it accepts patients under medicare ESRD program.
| Name | Nephron Dialysis Center, Ltd. |
|---|---|
| Location | 5140 N. California Ave., Chicago, Illinois |
| No. of Dialysis Stations | 16 |
| Medicare ID | 142600 |
| Ownership Type | Profit |
| Late Shifts | No |
| 5140 N. California Ave., Chicago, Illinois, 60625 | |
| (773) 293-2100 | |
| NPI Number | 1356362941 |
| Match | Possible same name, address or phone number |
| Organization Name | Nephron Dialysis Center Ltd |
| Address | 5140 N California Ave, Chicago, Illinois 60625 |
| Phone Number | (773) 293-2100 |
| Dialysis patients with Hemoglobin data | 25 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 44 |
For adult patients on hemodialysis, Kt/V should be at least 1.2 and for peritoneal dialysis at least 1.7; that means they are receiving the right amount of dialysis. For pediatric patients, Kt/V should be at least 1.2 on hemodialysis and 1.8 on peritoneal dialysis.
Higher percentages are better.
| Adult patients getting regular hemodialysis at the center | 81 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 737 |
| Percentage of adult hemodialysis patients with Kt/V greater than or equal to 1.2 | 98 |
| Adult patients getting regular peritoneal dialysis at the center | 1 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 8 |
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Nephron Dialysis Center, Ltd. with elevated calcium levels.
| Patients in the hypercalcemia summary | 86 |
| Hypercalcemia patient months | 797 |
| Patients in the serum phosphorus summary | 94 |
| Percentage of patients with serum phosphorus less than 3.5 mg/dL | 11 |
| Percentage of patients with serum phosphorus from 3.5 to 4.5 mg/dL | 25 |
| Percentage of patients with serum phosphorus from 4.6 to 5.5 mg/dL | 26 |
| Percentage of patients with serum phosphorus from 5.6 to 7 mg/dL | 24 |
| Percentage of patients with serum phosphorus greater than 7 mg/dL | 14 |
The arteriovenous (AV) fistula is considered the best long-term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arteriovenous fistula and catheter summaries | 94 |
| Patient months included in arteriovenous fistula and catheter summaries | 850 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistula for their treatment | 69.4 |
| Percentage of patients receiving treatment through a vascular catheter for 90 days or longer | 23 |
The rate of hospitalization shows you whether patients who were being treated regularly at Nephron Dialysis Center, Ltd. were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standardized Hospitalization Ratio (SHR) Period | January, 2024 - December, 2024 |
| Patients in facility's Hospitalization Summary | 64 |
| Hospitalization Rate in facility | 133.3 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 227.8 |
| Hospitalization Rate: Lower Confidence Limit | 83 |
The rate of readmission shows you whether patients who were being treated regularly at Nephron Dialysis Center, Ltd. were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standardized Readmission Ratio (SRR) Period | January, 2024 - December, 2024 |
| Readmission Rate in facility | 44.8 (Worse than Expected) |
| Readmission Rate: Upper Confidence Limit | 63 |
| Readmission Rate: Lower Confidence Limit | 28.1 |
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Nephron Dialysis Center, Ltd. get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standardized Infection Ratio (SIR) Period | January, 2024 - December, 2024 |
| Infection Ratio in facility | 0.12 (Better than Expected) |
| SIR: Upper Confidence Limit | 0.59 |
| SIR: Lower Confidence Limit | 0.01 |
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Nephron Dialysis Center, Ltd.'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standardized Transfusion Ratio (STrR) Period | January, 2024 - December, 2024 |
| Patients in facility's Transfusion Summary | 23 |
| Transfusion Rate in facility | 22.6 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 122.8 |
| Transfusion Rate: Lower Confidence Limit | 6.3 |
The rate of mortality shows you whether patients who were being treated regularly at Nephron Dialysis Center, Ltd. lived longer than expected (better than expected), did not live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standardized Mortality Ratio (SMR) Period | January, 2021 - December, 2024 |
| Patients in facility's Survival Summary | 301 |
| Mortality Rate in facility | 19.3 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 28.4 |
| Mortality Rate: Lower Confidence Limit | 13.5 |
Davita Beverly Dialysis Location: 8109 South Western Ave, Chicago, Illinois, 60620 Phone: (773) 778-0173 |
Davita Brickyard Dialysis Location: 2640 N. Narragansett Ave. Suite D8, Chicago, Illinois, 60639 Phone: (773) 622-6345 |
Davita Brighton Park Dialysis Location: 4737 S. California Ave., Chicago, Illinois, 60632 Phone: (773) 523-2441 |
Davita Emerald Dialysis Location: 710 West 43rd Street, Chicago, Illinois, 60609 Phone: (773) 843-5668 |